FairJourney Biologics

FairJourney Biologics is a leader in antibody discovery, engineering and manufacturing services. Serving the global biopharma market from its headquarters in Porto, Portugal, FairJourney is science-led and customer focused, benefiting from a uniquely technically skilled workforce – over 90% of employees are PhD or MSc qualified. FairJourney specialise in phage display technology and have completed over 460 projects with more than 70 global partners including academic institutions, biotech, mid-size and large pharma companies with a market leading antibody discovery success rate exceeding 99%.

FairJourney Biologics
all, PharmaBio, Current
Investment date
January 2020
Deal status
Our portfolio